Maureen Mullarkey

E5531, a Pure Endotoxin Antagonist of High Potency

William J. Christ, Osamu Asano, Andrea L. C. Robidoux et al. · Science · 1995 · 321 citations

Pharmacotherapy, Viable Escherichia Coli, Drug Resistance +16

Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist

Maureen Mullarkey, Jeffrey Rose, John R. Bristol et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 290 citations

Total Synthesis of the Proposed Structure of Rhodobacter sphaeroides Lipid A Resulting in the Synthesis of New Potent Lipopolysaccharide Antagonists

William J. Christ, Pamela D. McGuinness, Osamu Asano et al. · Journal of the American Chemical Society · 1994 · 87 citations

Lipid Analysis, Bioorganic Chemistry, Altmetric Attention Score +18

A Novel Class of Endotoxin Receptor Agonists with Simplified Structure, Toll-Like Receptor 4-Dependent Immunostimulatory Action, and Adjuvant Activity

Lynn D. Hawkins, Sally T. Ishizaka, Pamela D. McGuinness et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 62 citations

Consequences of Interaction of a Lipophilic Endotoxin Antagonist with Plasma Lipoproteins

Jeffrey Rose, Maureen Mullarkey, William J. Christ et al. · Antimicrobial Agents and Chemotherapy · 2000 · 36 citations · Full text